Psychosocial stressors and mammary tumor growth: An animal model

Neurotoxicology and Teratology

Volumn 22, Issue 1, 2000, Pages 89-102

  Strange, Karen S ^a   Kerr, Leslie R ^a   Andrews, Heather N ^a   Emerman, Joanne T ^a   Weinberg, Joanne ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Animal model; Mammary tumor growth; Psychosocial stressors

Indexed keywords

CORTICOSTERONE; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST TUMOR; CANCER GROWTH; CONTROLLED STUDY; COPING BEHAVIOR; DISEASE ASSOCIATION; GROWTH RATE; HOUSING; LIFE EVENT; MALE; MENTAL STRESS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS; DISEASE MODELS, ANIMAL; ENDOCRINE GLANDS; FEMALE; HEAT-SHOCK PROTEINS; HUMANS; IMMUNE SYSTEM; KILLER CELLS, NATURAL; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; SOCIAL BEHAVIOR; SOCIAL CONDITIONS; STRESS, PSYCHOLOGICAL;

EID: 0033957738     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0892-0362(99)00049-5     Document Type: Article

References (154)

1. A.K. Abbas, A.H. Lichtman, J.S. Pober (Eds.), Cellular and Molecular Immunology, W.B. Saunders Co., Philadelphia, 1994.
2. Amario A., Castellanos J.M. A comparison of corticoadrenal and gonadal responses to acute immobilization stress in rats and mice. Physiol Behav. 32:1984;517-519.
3. Amkraut A., Solomon G.F. Stress and murine sarcoma virus (Maloney)-induced tumors. Cancer Res. 32:1972;1428-1433.
4. Armario A., Lopez-Calderon A. Pituitary gonadal function in adult male rats subjected to crowding. Endocr Res. 12:1986;115-122.
5. Armitage J.D. Tumor proliferative rate and response to chemotherapy. Ann Intern Med. 116:1992;771-772.
6. Asterita M.F. The physiology of stress. 1985;with special reference to the neuroendocrine system. Human Science Press Inc, New York.
7. Auphan N., DiDonato J.A., Rosette C., Helmberg A., Karin M. Immunosuppresion by glucocorticoids. Inhibition of NFκB activity through induciton if IκB synthesis Science. 270:1995;286-290.
8. Axelrod J., Reisine T.D. Stress hormones. Their interaction and regulation Science. 224:1984;454-459.
9. Banerjee R., Ginsberg E., Vonderhaar B.K. Characterization of a monoclonal antibody against human prolactin receptors. Int J Cancer. 55:1993;712-721.
10. Bassukas I.D., Maurer-Schultze B. Lethal toxicity of cyclophosphamide depends on the tumor stage. Studies on the syngeneic adenocarcinoma EO771 in C56bl/6j mice. Anticancer Res. 13:1993;827-834.
11. Beden S.N., Brain P.F. Studies on the effect of social stress on measures of disease resistance in laboratory mice. Aggres Behav. 8:1982;126-129.
12. Ben-Eliyahu S., Page G.G. In vitro assessment of natural killer cell activity. Neuroendocrinol Immunol. 5:1992;199-214.
13. Ben-Nathan D., Feuerstein G. The influence of cold or isolation stress on resistance of mice to West Nile Virus encephalitis. Experientia. 46:1990;285-290.
14. Bernton E.W., Meltzer M.S., Holaday J.W. Suppression of macrophage activation and T lymphocyte function in hypoprolactinemic mice. Science. 239:1988;401-404.
15. Blalock J.E. A molecular basis for bidirectional communication between the immune and neuroendocrine systems. Physiol Rev. 69:1989;1-32.
16. Boddy A.V., Idle J.R. The role of pharmacogenetics in chemotherapy. Modulation of tumor response and host toxicity Cancer Surveys. 17:1993;79-104.
17. Brain P.F., Nowell N.W. The effects of differential grouping on endocrine function of mature male albino mice. Physiol Behav. 5:1970;907-910.
18. Brain P.F. What does individual housing mean to a mouse? Minireview. Life Sci. 16:1975;187-200.
19. Brain P.F., Nowell N.W. Effect of prior housing on adrenal response to isolation grouping in male albino mice. Psychonom Sci. 22:1971;183.
20. Brayton A.R., Brain P.F. Studies of effect of differential housing on some measures of disease resistance in male and female laboratory mice. J Endocrinol. 61:1974;R48-R49.
21. Bronson F.H. Establishment of social rank among grouped male mice. Relative effects on circulating FSH LH, and corticosterone, Physiol Behav. 10:1972;947-951.
22. Brunda M.J., Bellantoni D., Sulich V. In vivo anti-tumor activity of combinations of interferon alpha and interleukin-2 in a murine model. Correlation of efficacy with the induction of cytotoxic cells resembling natural killer cells. Int J Cancer. 40:1978;365-371.
23. Burchfield S.R., Woods S.C., Elich M.S. Effects of cold stress on tumor growth. Physiol Behav. 21:1978;537-540.
24. Burish T.G., Carey M.P., Krozely M.G., Greco F.A. Conditioned side-effects induced by cancer chemotherapy. Prevention through behavioral treatment J Consult Clin Psychol. 55:1987;42-48.
25. Chiueh C.C., McCarty R. Sympatho-adrenal hyperreactivity to footshock stress but not to cold exposure in spontanteously hypertensive rats. Physiol Behav. 26:1981;85-89.
26. Christian J.J., Davis D.E. Endocrines, behavior and population. Science. 146:1964;1550-1560.
27. Christian J.J., Lloyd J.A., Davis D.E. The role of endocrines in the self-regulation of mammalian populations. Rec Prog Horm Res. 21:1965;501-578.
28. Clifton K.H. Animal models of breast cancer. Rose D.P. Endocrinology of Cancer, Vol. 1. 1979;1-20 CRC Press, Inc, Boca Raton, FL.
29. Corbett T.H., Griswold D.P. Jr., Roberts B.J., Puekham J.C., Schabel F.M. Jr. Biology and therapeutic response of a mouse mammary adenocarcinoma (16/c) and its potential as a model for surgical adjuvant chemotherapy. Cancer Treat Rep. 62:1978;1471-1488.
30. Daneshgari F., Crawford E.D. Endocrine therapy of advanced carcinoma of the prostate. Cancer. 71:1993;1089-1097.
31. Dechambre R.P., Gosse C. Individual vs group caging of mice with grafted tumors. Cancer Res. 33:1973;140-144.
32. Dillman R.O., Koziol J.A., Zavanelli M., Beauregard J.C., Halliburton B.L., Glassy M.C., Royston I. Immunoincompetence in cancer patients. Assessment by in vitro stimulation tests and quantification of lymphocyte subpopulations. Cancer. 53:1984;1484-1491.
33. Ebbesen P., Villadsen J.A., Villadsen H.D., Heller K.E. Effect of subordinance, lack of social hierarchy, and restricted feeding on murine survival and virus leukemia. Exp Gerontol. 26:1991;479-486.
34. Edwards D.P., Eates P.A., Valeris A., Fadok B.J., Onate S., Nordeen S.K., Welch W.J. Heat shock alters the composition of heteromeric steroid receptor complexes and enhances receptor activity in vivo. Biochemistry. 31:1992;2482-2491.
35. Edwards E.A., Dean L.M. Effects of crowding of mice on humoral antibody formation and protection to lethal antigenic challenge. Psychosom Med. 39:1977;19-24.
36. Emerman J.T., Siematkowski J. Effects of endocrine regulation of growth of a mouse mammary tumor on its sensitivity to chemotherapy. Cancer Res. 44:1984;1327-1332.
37. Fawzy F.I., Kemeny M.E., Fawzy N.W., Elashoff R., Morton D., Cousins N., Fahey J.L. A structured psychiatric intervention for cancer patients. II. changes over time in immunological measures. Arch Gen Psychiatry. 47:1990;729-735.
38. Fidler I.J. Systemic macrophage activation with liposome-entrapped immunomodulators for therapy of cancer metastasis. Res Immunol. 143:1992;199-204.
39. Fischer E.G. Opioid peptides modulate immune functions. A review. Immunopharmacol Immunotoxicol. 10:1988;265-326.
40. Fjuita M.Q., Yasui T., Sato B., Uchida N., Uchida K., Shiratori O., Takeda K., Matsumoto K. Maintenance of androgen-, glucocorticoid-, or estrogen responsive growth in Shionogi carcinoma 115 subline sustained in castrated mice with high dose of estrogen for 30 generations (3 years). Jpn J Cancer Res. 83:1992;995-1001.
41. Fox B.H. Psychosocial factors and the immune system in human cancer. Ader R. Psychoneuroimmunology. 1981;103-157 Academic Press, New York.
42. Frances H., Khidichian F., Monier C. Increases in the isolation-induced social behavioral deficit by agonists at 5-HT1A receptors. Neuropharmacology. 29:1990;103-107.
43. Frankel A.I., Ryan E.L. Testicular innervation is necessary for the response of plasma testosterone levels to acute stress. Biol Reprod. 24:1981;491-495.
44. Friedman S.B., Ader R. Adrenocortical response to novelty and noxious stimulation. Neuroendocrinology. 2:1967;209-212.
45. Friedman S.B., Glasgow L.A., Ader R. Psychosocial factors modifying host resistance to experimental infections. Ann NY Acad Sci. 164:1969;381-392.
46. Gentsch C., Lichtsteiner M., Feer H. Competition for sucrose-pellets in triads of male Wistar rats. Disinhibitory effect of individual housing in poor-performing rats Behav Brain Res. 38:1990;19-24.
47. Gerson J.M., Tagliabue A., Herberman R.B. Systemic and in situ natural killer activity in transplanted and spontaneous mammary tumors in C3H/HeN mice. J Reticuloendothel Soc. 29:1981;15-22.
48. Giraldi T., Perissin L., Zorzet S., Rapozzi V. Metastases and neuroendocrine system in stressed mice. Ann NY Acad Sci. 650:1992;297-301.
49. T. Giraldi, L. Perissin, S. Zorzet, V. Rapozzi, Stress and the Effectiveness of Antitumor Chemotherapy in Mice, First International Congress on Stress, Bethesda, MD, 1994.
50. Giraldi T., Perissin L., Zorzet S., Rapozzi V. Stress, melatonin and tumor progression in mice. Ann NY Acad Sci. 719:1994;526-536.
51. Giralt M., Armario A. Individual housing does not influence the adaptation of the pituitary adrenal axis and other physiological variables to chronic stress in adult male rats. Physiol Behav. 45:1987;477-481.
52. Greenberg A.H., Khalil N., Pohajdak B., Talgoy M., Henkart P., Orr F.W. NK-leukocyte chemotactic factor (NK-LCF). A large granular lymphocyte (LGL) granule-associated chemotactic factor J Immunol. 137:1986;3224-3230.
53. Greenberg P.D. Adoptive T cell therapy of tumors. Mechanisms operative in the recognition and elimination of tumor cells Adv Immunol. 49:1991;281-355.
54. Greer S., Morris T. Psychological attributes of women who develop breast cancer. A controlled study J Psychosom Res. 19:1975;147-153.
55. Greer S., Morris T., Pettingale K.W. Psychological response to breast cancer. Effect on outcome Lancet. 2:1979;785-787.
56. Grimm M.S., Emerman J.T., Weinberg J. Effects of social housing condition and behavior on growth of the Shionogi mouse mammary carcinoma. Physiol Behav. 59:1996;633-642.
57. Grossarth-Maticek R., Eysenck H.J. Length of survival and lymphocyte percentage in women with mammary cancer as a function of psychotherapy. Psychol Rep. 65:1989;315-321.
58. Grossman C.J., Roselle G.A. The control of immune response by endocrine factors and the clinical significance of such regulation. Prog Clin Biochem Med. 4:1987;9-56.
59. Grossman C.J. Are there underlying immune-neuroendocrine interactions responsible for immunological sexual dimorphism? Prog Neuroendocrinol. 3:1990;75-82.
60. Grossman C.J. Interactions between the gonadal steroids and the immune system. Science. 227:1985;257-261.
61. Haller O., Hansson M., Kiessling R., Wigzell H. Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo. Nature. 270:1977;609-611.
62. Hatch A.M., Wibery G.S., Zawidzka Z., Cann M., Airth J.M., Grice H.C. Isolation syndrome in the rat. Toxicol Appl Pharmacol. 7:1965;737-745.
63. Hennessy M.B., Levine S. Effects of various habituation procedures on pituitary-adrenal responsiveness in the mouse. Physiol Behav. 18:1977;799-802.
64. Herberman R.B. Introduction. Herberman R.B., Callewaert D.M. Mechanisms of Cytotoxicity by NK Cells. 1985;1-13 Academic Press Inc, Orlando, FL.
65. Herberman R.B., Ortaldo J.R. Natural killer cells. Their role in defence against disease Science. 214:1981;24-30.
66. Hiraoka D., Nakamura N., Nishizawa Y., Uchida N., Noguchi S., Matsumoto K., Sato B. Inhibitory and stimulatory effects of glucocorticoids on androgen-induced growth of murine Shionogi carcinoma 115 in vivo and in cell culture. Cancer Res. 47:1987;6560-6564.
67. Hislop T.G., Waxler N.E., Coldman A.J., Elwood J.M., Kan L. The prognostic significance of psychosocial factors in women with breast cancer. J Chron Dis. 40:1987;729-735.
68. Hoffman R.A. Characterization of natural killer activity in sponge matrix allografts. J Immunol. 140:1988;1702-1710.
69. Ito Y., Mine K., Ago Y., Nakagawa T., Fujiwara M., Ueki S. Attack stress and IgE antibody production in rats. Pharmacol Biochem Behav. 19:1983;883-886.
70. Jaaskelainen J., Kalliomake P., Paetau A., Timonen T. Effect of LAK cells against three-dimensional tumor tissue. In vitro study using multi-cellular human glioma spheroids as targets. J Immunol. 142:1989;1036-1045.
71. Jameel A., Skilton R.A., Campbell S.K., Coombes R.C., Luqman Y.A. Clinical and biological significance of HSP 89α in human breast cancer. Int J Cancer. 50:1992;409-415.
72. Johnson E.O., Kamilaris T.C., Chrousos G.P., Gold P.W. Mechanisms of stress. A dynamic overview of hormonal and behavioral homeostasis Neurosci Biobehav Rev. 16:1992;115-130.
73. Jurcovicova J., Vigas M., Klir P., Jezova D. Response of prolactin, growth hormone and corticosterone secretion to morphine administration or stress exposure in Wistar-AVN and Long Evans rats. Endocrinol Exp. 18:1984;209-214.
74. Justice A. Review of the effects of stress on cancer in laboratory animals. Importance of time of stress application and type of tumor Psychol Bull. 98:1985;108-138.
75. Keiss W., Belohradsky B.H. Endocrine regulation of the immune system. Klin Wochenschr. 64:1986;1-7.
76. Kerr L.R., Grimm M.S., Silva W.A., Weinberg J., Emerman J.T. Chemotherapeutic efficacy. Influence of psychosocial stressors Cancer Res. 57:1997;1124-1128.
77. R.B.J. King, J. Yates, The use of cultured mammary tumor cells to study effects of steroid hormones, in: R.J. Richards, K.T. Rajan (Eds.), Tissue Culture in Medical Research II: Proceedings of the Second International Symposium, Cardiff, Wales, UK, April 103, Pergamon Press, New York, 1980, pp. 221-227.
78. Koike S., Noumura T. Effects of post weaning differential housing on serum testosterone levels in male mice through-out aging. Zool Sci. 6:1989;351-358.
79. Kopp E.B., Ghosh S. NFκB and Rel proteins in innate immunity. Adv Immunol. 58:1995;1-27.
80. Lazarus R.S. The concepts of stress and disease. Levi L. Society, Stress and Disease. 1971;53-58 Oxford University Press, New York.
81. Leung C.K., Shiu R.P. Required presence of both estrogen and pituitary factors for the growth of human breast cancer cells in athymic nude mice. Cancer Res. 41:1981;546-551.
82. Levine S., Weinberg J., Brett L.P. Inhibition of pituitary-adrenal activity as a consequence of consummatory behavior. Psychoneuroendocrinology. 4:1979;275-286.
83. S. Levine, J. Weinberg, H. Ursin, Definition of the coping process and statement of the problem, in: Psychobiology of Stress: A Study of Coping Men, Academic Press Inc., New York, 1978.
84. Levy S., Herberman R., Lippman M., d'Angelo T. Correlation of stress factors with sustained depression of natural killer cell activity and predicated prognosis in patients with breast cancer. J Clin Oncol. 5:1987;348-353.
85. Lichtman R.R., Taylor S.E., Wood J.V. Social support and marital adjustment after breast cancer. J Psychosoc Oncol. 5:1987;47-74.
86. Lippman M.E. Psychosocial factors and the hormonal regulation of tumor growth. Levy S.M. Behavior and Cancer. 1985;Jossey-Boss Publishers, San Francisco, CA.
87. Locke S.E. Stress, adaptation and immunity. Studies in humans Gen Hosp Psychiatry. 4:1982;49-58.
88. Maclean G.D., Longenecker B.M. New possibilities for cancer therapy with advances in cancer immunology. Can J Onco. 4:1994;249-254.
89. Mandler R.N., Biddison W.E., Mandler R., Serrate S.A. Beta-endorphin augments the cytolytic activity and interferon produciton of nautral killer cells. J Immunol. 136:1986;934-939.
90. Manni A. Somatostatin and growth hormone regulation in cancer. Biotherapy. 4:1992;31-36.
91. Mason J.W. A historical view of the stress field. Part I J Hum Stress. 1:1975;6-12.
92. Mason J.W. A historical view of the stress field. Part II J Hum Stress. 1:1975;22-36.
93. Migliori F.J., Gruber S.A., Sawyer M.D., Hoffman R., Ochoa A., Bach F.H., Simmons R.L. Lymphokine-activated killer (LAK) cells can be focused at sites of tumor growth by products of macrophage activation. Surgery. 102:1987;155-161.
94. Morley J.E., Kay N.E., Solomon G.F., Plotnikoff N.P. Neuropeptides. Conductors of the immune orchestra Life Sci. 41:1987;527-544.
95. Munck A., Guyre P.M., Holbrook N.J. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev. 5:1984;25-44.
96. Nakamura N., Yamanishi H., Lu J., Uchida N., Nonomura N., Matsumoto K., Sato B. Growth-stimulatory effects of androgen, high concentration of glucocorticoid or fibroblast growth factors on a cloned cell line from Shionogi carcinoma 115 cells in a serum-free medium. J Steroid Biochem. 33:1989;13-18.
97. Newberry B.H., Liebelt A.G., Boyle D.A. Variables in behavioral oncology. Overview and assessment of current issues Fox B.H., Newberry B.H. Impact of Psychoneuroendocrine Systems on Cancer and Immunity. 1984;86-146 C.J. Hogrefe, Inc, Toronto.
98. Noguchi A., Nishizawa Y., Makamura N., Uchida N., Yamaguchi K., Sato B., Kitamura Y., Matsumoto K. Growth-stimulating effect of pharmacological doses of estrogen on androgen-dependent Shionogi carcinoma 115 in vivo but not in cell culture. Cancer Res. 47:1987;263-268.
99. Oesterrich S., Weng C.N., Hilsenbeck S.G., Osborne C.K., Fuqua S.A.W. The small heat shock protein hsp 27 is correlated with growth and drug resistance in human breast cancer cell lines. Cancer Res. 53:1993;4443-4448.
100. Olivier B., Mos J., van der Heyden J., Hartog J. Serotonergic modulation of social interactions in isolated male mice. Psychopharmacology (Berlin). 97:1989;154-156.
101. Omukai Y., Makamura N., Hiraoka D., Nishizawa Y., Uchida N., Noguchi S., Sato B., Matsumoto K. Growth-stimulating effect of pharmacological doses of glucocorticoid on androgen-responsive Shionogi carcinoma 115 in vivo in mice and in cell culture. Cancer Res. 47:1987;4329-4334.
102. Orr T.E., Meyerhoff J.L., Mougey E.H., Bunnell B.N. Hyperresponsiveness of the rat neuroendocrine system due to repeated exposure to stress. Psychoneuroendocrinology. 15:1990;317-328.
103. Ortiz R., Armario A., Castellanos J.M. Post-weaning differential housing and testosterone secretion in male mice. Experientia. 40:1984;1428-1429.
104. Ortiz R., Armario A., Castellanos J.M., Balasch J. Post-weaning crowding induces corticoadrenal hyperreactivity in male mice. Physiol Behav. 34:1985;857-860.
105. Pasqualini J.R. Role of androgens in breast cancer (review). J Steroid Biochem Mol Biol. 45:1993;167-172.
106. Peng X., Lang C.M., Drozdowicz C.K., Ohlsson-Wilhelm B.M. Effect of cage population density on plasma corticosterone and peripheral lymphocyte populations of laboratory mice. Lab Anim. 23:1989;302-306.
107. Perissin L., Zorzet S., Piccini P., Rapozzi V., Giraldi T. Effects of rotational stress on the effectiveness of cyclophosphamide and razoxane in mice bearing Lewis lung carcinoma. Clin Exp Metast. 9:1991;541-549.
108. Pfister H.P., King M.G. Adaptation of the glucocorticoid response to novelty. Physiol Behav. 17:1976;43-46.
109. Plaut P., Freidman S.B., Ader R., Ritterson A.L., Grota L.J. Role of prolactin in growth of the rat mammary tumor MTW9. Int J Cancer. 48:1991;109-112.
110. Raab A., Danzter R., Michaud B., Mormede P., Taghzouti K., Simon H., LeMoal M. Behavioural, physiological and immunological consequences of social status and aggression in chronically coexisting resident-dyads of male rats. Physiol Behav. 36:1986;223-228.
111. Rabin B.S., Lyte M., Epstein L.H., Caggiula A.R. Alteration of immune competency by number of mice housed per cage. Ann NY Acad Sci. 496:1987;492-500.
112. Rabin B.S., Lyte M., Hamill E. The influence of mouse strain and housing on the immune response. J Neuro Immunol. 17:1987;11-16.
113. Rajpert-De Meyts E., Skakkebaek N.E. The possible role of sex hormones in the development of testicular cancer. Eur Urol. 23:1993;54-59.
114. Reichlin S. Neuroendocrine-immune interactions. N Eng J Med. 329:1993;1246-1253.
115. Restrepo C., Armario A. Comparison of crowding and food restriction effects on growth, body weight gain and endocrine status in the rat. Reprod Nutr Dev. 29:1989;339-345.
116. Riley V. Psychoneuroendocrine influences on immunocompetence and neoplasia. Science. 2121:1981;1100-1109.
117. Riley V., Fitzmaurice M.A., Spackman D.H. Psychoneuroimmunologic factors in neoplasia. Studies in animals Ader R. Psychoneuroimmunology. 1981;31-102 Academic Press, New York.
118. Rivier C., Rivest S. Effect of stress on the activity of the hypothalamic pituitary gonadal axis. Peripheral and central mechanisms Biol Reprod. 45:1991;523-532.
119. Roberts P.J., Hayry P. Sponge matrix allografts. A model for analysis of killer cells infiltrating mouse allografts. Transplantation. 21:1976;437-445.
120. Rodriguez-Enchandia E.L., Gonzalez A.S., Cabrera R., Fracchia L.N. A further analysis of behavioral and endocrine effects of unpredictable chronic stress. Physiol Behav. 43:1988;789-795.
121. Rose D.P., Noonan J.J. Influence of prolactin and growth hormone on rat mammary tumors induced by N-nitrosomethylurea. Cancer Res. 42:1982;35-38.
122. Rowse G.J., Rowan R.E., Weinberg J., Emerman J.T. Alterations in splenic natural killer cell activity induced by the Shionogi mouse mammary tumor. Cancer Lett. 54:1990;81-87.
123. Rowse G.J., Weinberg J., Bellward G.D., Emerman J.T. Endocrine mediation of psychosocial stressor effects on mouse mammary tumor growth. Cancer Lett. 65:1992;85-93.
124. Rowse G.J., Weinberg J., Emerman J.T. Role of natural killer cells in psychosocial stressor-induced changes in mouse mammary tumor growth. Cancer Res. 55:1995;617-622.
125. Salvin S.B., Rabin B.S., Neta R. Evaulation of immunological assays to determine the effects of differential housing on immune reactivity. Brain Behav Immun. 4:1990;180-188.
126. Sapolsky R.M. Stress-induced elevation of testosterone concentrations in high ranking baboons. Role of catecholamines Endocrinology. 118:1986;1630-1635.
127. Sapolsky R. Cortisol concentrations and the social significance of rank instability among wild baboons. Psychoneuroendocrinology. 17:1992;701-709.
128. Sayegh J.F., Kobor G., Lajtha A., Vadasz C. Effects of social isolation and the time of day on testosterone levels in plasma of C57BL/6By and Balb/cBy mice. Steroids. 55:1990;79-82.
129. Scheinman R.I., Cogswell P.C., Lofquist A.K., Baldwin A.S. Jr. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science. 270:1995;283-286.
130. Selye H. Confusion and controversy in the stress field. J Hum Stress. 1:1975;37-44.
131. Selye H. The evolution of the stress concept. Am Sci. 61:1973;692-699.
132. Shanks N., Griffiths J., Zalcman S., Zacharo R.M., Anisman J. Mouse strain differences in plasma corticosterone following uncontrollable footshock. Pharmacol Biochem Behav. 36:1990;515-519.
133. Simpson-Herren L., Noker P.E., Wagoner S.D. Variability of tumor response to chemotherapy II. Contribution of tumor heterogeneity. Cancer Chemother Pharmacol. 22:1988;131-136.
134. Sklar L.S., Anisman H. Stress and cancer. Psychol Bull. 89:1981;369-406.
135. Sklar L.S., Anisman H. Social stress influences tumor growth. Psychosom Med. 42:1980;347-365.
136. Spiegel D. Psychosocial aspects of breast cancer treatment. Semin Oncol. 24(suppl 1):1997;36-47.
137. Spiegel D., Bloom J.R., Kraemer H.C., Gottheil E. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet. 2:1989;888-891.
138. Stein M., Schiavi R.C., Camerino M. Influence of brain and behavior on the immune system. Science. 191:1976;435-440.
139. Takahashi S., Mikami T., Watanabe Y., Okazaki M., Yutaka O., Okazaki A., Sato T., Asaishi K., Hirata K., Narimatsu E., Mori M., Sato N., Kikuchi K. Correlation of heat shock protein level 70 expression with estrogen receptor levels in invasive human breast cancer. Anatom Pathol. 101:1994;519-525.
140. Temoshok L., Fox B.H. Coping styles and other psychological factors related to medical status and to prognosis in patients with cutaneous malignant melanoma. Fox B.H., Newberry B.H. Impact of Psychoendocrine Systems in Cancer and Immunity. 1984;258-287 Hogrefe, New York.
141. Uchida N., Yamaguchi K., Narita N., Nakao K., Kitamura Y., Matsumoto K. Adjuvant chemo-endocrine therapy for androgen-dependent mammary tumor in mice. Breast Cancer Res Treat. 1:1981;69-75.
142. Ueo H., Matsuoka H., Duhimsvhi K., Kuwano H., Mori M., Akiyoshi T. Inhibitory effects of estrogen on the growth of a human esophageal carcinoma cell line. Cancer Res. 50:1990;7212-7215.
143. Valzelli L. The isolation syndrome in mice. Psychopharmacolgia. 31:1973;305-320.
144. Vessey S.H. Effects of grouping on levels of circulating antibodies in mice. Soc Exp Biol Med. 115:1964;252-255.
145. Watanabe S., Nohno T., Omukai Y., Saito T., Senoo T. Stimulatory effects of dexamethasone and indomethacin on growth of androgen-dependent Shionogi carcinoma 115 in the mouse. Cancer Lett. 16:1982;261-266.
146. Waxler-Morrison N., Hislop T.G., Mears B., Kan L. Effects of social relationships on survival for women with breast cancer. A prospective study Soc Sci Med. 33:1991;177-183.
147. Weber R.P., Pert C.B. Opiatergic modulation of the immune system. Muller E.E., Genazzani A.R. Central and Peripheral Endorphins. Basic and Clincial Aspects:1984;35-42 Raven Press, New York.
148. Wei W.Z., Heppner G. Natural killer activity of lymphocytic infiltrates in mouse mammary lesions. Br J Cancer. 55:1987;589-594.
149. Weinberg J., Levine S. Psychobiology of coping in animals. The effects of predictability Levine S., Ursin H. Coping and Health. 1980;39-59 Plenum Press, New York.
150. Weinberg J., Emerman J.T. Effects of psychosocial stressors on mouse mammary tumor growth. Brain Behav Immun. 3:1989;234-246.
151. Welch W.J. Mammalian stress response. Cell physiology, structure/function of stress proteins, and implications for medicine and disease Physiol Rev. 72:1992;1063-1081.
152. Whitworth P.W., Pak C.C., Esgro J., Kleinerman E.S., Fidler I.J. Macrophages and cancer. Cancer Metast Rev. 8:1990;319-351.
153. Yates J., King R.J. Correlation of growth properties and morphology with hormone responsiveness of mammary tumor cells in culture. Cancer Res. 41:1981;258-262.
154. Zangemeister-Wittke U., Kyewski B., Schirrmacher V. Recruitment and activation of tumor-specific immune T cells in situ. CD8+ cells predominate the secondary response in sponge matrices and exert both delayed-type hypersensitivity-like cytotoxic T lymphocyte activity. J Immunol. 143:1989;379-385.